378 related articles for article (PubMed ID: 24024876)
1. Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?
Niciu MJ; Henter ID; Sanacora G; Zarate CA
World J Biol Psychiatry; 2014 Jan; 15(1):2-16. PubMed ID: 24024876
[TBL] [Abstract][Full Text] [Related]
2. Glial and neuroinflammatory targets for treating substance use disorders.
Bachtell RK; Jones JD; Heinzerling KG; Beardsley PM; Comer SD
Drug Alcohol Depend; 2017 Nov; 180():156-170. PubMed ID: 28892721
[TBL] [Abstract][Full Text] [Related]
3. The role of glial cells in drug abuse.
Miguel-Hidalgo JJ
Curr Drug Abuse Rev; 2009 Jan; 2(1):72-82. PubMed ID: 19630738
[TBL] [Abstract][Full Text] [Related]
4. Gliogenesis and glial pathology in depression.
Rajkowska G; Miguel-Hidalgo JJ
CNS Neurol Disord Drug Targets; 2007 Jun; 6(3):219-33. PubMed ID: 17511618
[TBL] [Abstract][Full Text] [Related]
5. Glial modulators as potential treatments of psychostimulant abuse.
Beardsley PM; Hauser KF
Adv Pharmacol; 2014; 69():1-69. PubMed ID: 24484974
[TBL] [Abstract][Full Text] [Related]
6. Glial mechanisms underlying substance use disorders.
Linker KE; Cross SJ; Leslie FM
Eur J Neurosci; 2019 Aug; 50(3):2574-2589. PubMed ID: 30240518
[TBL] [Abstract][Full Text] [Related]
7. The Role of Glial Cells in Drug Abuse.
Miguel-Hidalgo JJ
Curr Drug Abuse Rev; 2009; 2(1):76-82. PubMed ID: 19606280
[TBL] [Abstract][Full Text] [Related]
8. Depression and stimulant dependence: neurobiology and pharmacotherapy.
Kosten TR; Markou A; Koob GF
J Nerv Ment Dis; 1998 Dec; 186(12):737-45. PubMed ID: 9865811
[TBL] [Abstract][Full Text] [Related]
9. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis.
Markou A; Kosten TR; Koob GF
Neuropsychopharmacology; 1998 Mar; 18(3):135-74. PubMed ID: 9471114
[TBL] [Abstract][Full Text] [Related]
10. Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms.
Miguel-Hidalgo JJ; Wei J; Andrew M; Overholser JC; Jurjus G; Stockmeier CA; Rajkowska G
Biol Psychiatry; 2002 Dec; 52(12):1121-33. PubMed ID: 12488057
[TBL] [Abstract][Full Text] [Related]
11. Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy.
Bernstein HG; Steiner J; Guest PC; Dobrowolny H; Bogerts B
Schizophr Res; 2015 Jan; 161(1):4-18. PubMed ID: 24948484
[TBL] [Abstract][Full Text] [Related]
12. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
[TBL] [Abstract][Full Text] [Related]
13. A review of the neurobiological underpinning of comorbid substance use and mood disorders.
Gómez-Coronado N; Sethi R; Bortolasci CC; Arancini L; Berk M; Dodd S
J Affect Disord; 2018 Dec; 241():388-401. PubMed ID: 30145509
[TBL] [Abstract][Full Text] [Related]
14. Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression.
Kim YK; Na KS
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():117-26. PubMed ID: 27046518
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.
Torrens M; Fonseca F; Mateu G; Farré M
Drug Alcohol Depend; 2005 Apr; 78(1):1-22. PubMed ID: 15769553
[TBL] [Abstract][Full Text] [Related]
16. Suicide attempts in major affective disorder patients with comorbid substance use disorders.
Tondo L; Baldessarini RJ; Hennen J; Minnai GP; Salis P; Scamonatti L; Masia M; Ghiani C; Mannu P
J Clin Psychiatry; 1999; 60 Suppl 2():63-9; discussion 75-6, 113-6. PubMed ID: 10073390
[TBL] [Abstract][Full Text] [Related]
17. Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders.
Czéh B; Nagy SA
Front Mol Neurosci; 2018; 11():56. PubMed ID: 29535607
[TBL] [Abstract][Full Text] [Related]
18. Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances.
Cooper ZD; Jones JD; Comer SD
Expert Opin Investig Drugs; 2012 Feb; 21(2):169-78. PubMed ID: 22233449
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.
Hauser KF; El-Hage N; Stiene-Martin A; Maragos WF; Nath A; Persidsky Y; Volsky DJ; Knapp PE
J Neurochem; 2007 Feb; 100(3):567-86. PubMed ID: 17173547
[TBL] [Abstract][Full Text] [Related]
20. Order of onset of substance abuse and depression in a sample of depressed outpatients.
Abraham HD; Fava M
Compr Psychiatry; 1999; 40(1):44-50. PubMed ID: 9924877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
